Please turn JavaScript on

PLOS Computational Biology

Following PLOS Computational Biology's news feed is very easy. Subscribe using the "follow" button on the top right and if you want to, choose the updates by topic or tag.

We will deliver them to your inbox, your phone, or you can use follow.it like your own online RSS reader. You can unsubscribe whenever you want with one click.

Keep up to date with PLOS Computational Biology!

PLOS Computational Biology: Our journal portfolio - PLOS

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  2.77 / day

Message History

by Kyle Ellrott, Venkat S. Malladi, Jean-Christophe Bélisle-Pipon, Emek Demir, Yael Bensoussan, Serghei Mangul, Alex A. T. Bui, Paul C. Boutros

Modern statistical and machine learning techniques are effective at describing, testing hypotheses and making predictions from complex data. This effectiveness is strongly influenced by the volume and heterogeneity of available d...

Read full story

by Pavlos Alexandros Dimitriou, Matteo D’Alessandro, Brian L. Chang, Valentinos Silvestros, Elisavet Constantinou, Costas Pitris, Panayiotis Kolios, Piet Van Mieghem

Using contact tracing data provided by the Cyprus Ministry of Health, infection trees for the first four waves of the COVID-19 epidemic are constructed. In these trees, nodes represent infected individuals, ...

Read full story

by Bjorge Meulemeester, Arco Bast, María Royo, Rieke Fruengel, Su Saka, Foivos Kastrinakis, Marcel Oberlaender

How can we identify the mechanistic origins of the electrophysiological activity that is recorded from neurons in the living brain? A promising strategy for addressing this question is to generate biologically realistic models of in vivo recorded neurons,...

Read full story

by Xiamin Leng, Alexander Fengler, Amitai Shenhav, Michael J. Frank

Response deadlines are commonly imposed in decision-making research to incentivize speedy decisions and sustained attention. This procedure frequently leads to a proportion of trials in which no response is made, and these omissions are often simply removed from the data during analysis. Here we show tha...

Read full story

by Tao Qu, Lingyan Yuan, Weiran Cui, Jiatian Tang, Zhitong Bing, Xianghong Xu, Jizheng Duan, Qiong Yang, Hui Cai

CLDN18.2 is a promising tumor-specific antigen; however, the development of therapeutic antibodies against it is challenged by the need for simultaneous optimization of affinity and developability. To address this, we present cdrGPT, a deep learning framework ...

Read full story